A distinct difference between the TgF344-AD and the 3xTg-AD models is the expression of neuronal loss, gliosis, neuroinflammation, and tau expression in TgF344-AD rats that is not reliant on implanted mutated human tau. This evidence concerns the gene MAPT and Alzheimer disease.